Polaris Quantum Biotech uncloaks with Fujitsu
Polaris Quantum Biotech, based in Durham NC, has come out of stealth mode. They’ve been working with Fujitsu on a new drug discovery platform. Using Fujitsu’s Digital Annealer, they can crunch over 1 billion molecules in their search for new lead molecules. This startup is an example of using quantum annealing, a subset of quantum computing, to solve optimization problems.
The current pilot is working on a drug for dengue fever, a disease spread by mosquitoes with over 100 million infections and 22,000 deaths every year.
Related Posts
Microsoft Debugs Quantum Software in Virtual Reality, Catches Up To Minority Report
In almost every Sci-Fi film, there is a scene where some scientist is manipulating holographic images with just their hands. Microsoft is…
IBM and Google are building it, but who will come?
Unlike many other sectors, the Quantum Computing sector has so far been dominated by a few major hardware developers: IBM, Google, D-Wave…
The Quantum British Invasion
In the race to develop Quantum Computing, in addition to facing challenges across the Pacific in the form of China’s Jiuzhang Computer, the…